Karel Pavelká
Karel Pavelká publishes mostly in Rheumatology, Immunology and Pathology and Forensic Medicine, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Osteoarthritis Treatment and Mechanisms.
- World rank
- #572,213 of 7,710,434 ranked researchers
- Rank in Czechia
- #872 of 39,303
- Works
- 848
- Citations
- 43k
- Citations per work
- 50.5
What does Karel Pavelká research?
Karel Pavelká's work is mostly in Medicine (50%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences42450.0%
- Medicine42450.0%
- Everything else32037.7%
- Life Sciences10412.3%
- 1Rheumatology36% of their works
- 2Immunology7% of their works
- 3Pathology and Forensic Medicine5% of their works
- 4Molecular Biology5% of their works
- 5Surgery5% of their works
- 6Pharmacology4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Osteoarthritis Treatment and Mechanisms
- Autoimmune and Inflammatory Disorders Research
- Inflammatory mediators and NSAID effects
- Systemic Lupus Erythematosus Research
- Systemic Sclerosis and Related Diseases
- Psoriasis: Treatment and Pathogenesis
Which keywords describe Karel Pavelká's research?
The keywords of their largest research topics: Inflammation, Autoantibodies, Cardiovascular Risk, Biological Therapy, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis and Cartilage.
- IL-17
- Fibrosis
- Antiphospholipid Syndrome
- Cancer
- Hemophagocytic Lymphohistiocytosis
- Cartilage
- Ankylosing Spondylitis
- Biological Therapy
- Autoantibodies
- Inflammation
- Cardiovascular Risk
- Rheumatoid Arthritis
- Spondyloarthritis
- Osteoarthritis
- Juvenile Idiopathic Arthritis
- Cyclooxygenase-2 Inhibitors
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Inflammation5303 topics
- Autoantibodies4743 topics
- Cardiovascular Risk4192 topics
- Biological Therapy3601 topic
- Rheumatoid Arthritis3601 topic
- Ankylosing Spondylitis1881 topic
- Spondyloarthritis1881 topic
- Cartilage1111 topic
- Osteoarthritis1111 topic
- Hemophagocytic Lymphohistiocytosis741 topic
- Juvenile Idiopathic Arthritis741 topic
- Cancer591 topic
- Cyclooxygenase-2 Inhibitors591 topic
- Antiphospholipid Syndrome581 topic
- Systemic Lupus Erythematosus581 topic
- Fibrosis561 topic
- Systemic Sclerosis561 topic
- IL-17551 topic
- TH17 Cells551 topic
Where does Karel Pavelká work?
Karel Pavelká's main affiliation in the publication record is Institute of Rheumatology, Czechia.
How many publications and citations does Karel Pavelká have?
OpenAlex counts 848 works and 42,800 citations for Karel Pavelká, an h-index of 76, ranking #572,213 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Karel Pavelká
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karel Pavelká. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.